HU-243Also known as 7-hydroxy-hexahydrocannabinol-DMH
A cannabinoid radioligand of extreme affinity (KD 45 pM), listed by name as a narcotic in France.
Harm-reduction warning
No characterised human dose: animal / in vitro data only. Effect profile, safety margin and acute toxicity are not documented in human clinical practice. Extremely potent compound: severe effects, seizures and deaths reported in the literature.
C₂₅H₄₀O₃
CAS 140835-14-9
- Family
- Synthetic CB receptor agonistResearch ligand or medicine
- Molar mass
- 388.60 g/mol
Updated on
In plain terms
HU-243 is a laboratory cannabinoid with an extreme affinity for the cannabis receptor, described in 1992 as a probe: its radioactive version was used to measure this receptor. It is not meant to be consumed, and it is classified as a narcotic in France.
Receptors and activity
Target network
- Activates
The lower the cited value, the closer the target sits to HU-243: one ring per factor of 100. A target with no measured value stays on the edge.
Where these targets live
Where each target has been found in humans, according to the cited studies. The map shows the target, not an effect of HU-243.
CB1CB1 found in 7 regions of the body
- Basal gangliadenseMost dense in basal ganglia outflow nuclei1
- CerebellumdenseVery dense in the cerebellum1
- HippocampusdenseVery high concentrations in the hippocampus2
- AmygdaladenseHigh concentrations in the amygdala2
- CortexpresentPresent throughout the neocortex2
- Adipose tissuepresentExpressed in adipose tissue3
- GutpresentColonic epithelium, smooth muscle and plexus4
Map sources
- Herkenham M et al. Cannabinoid receptor localization in brain. Proc Natl Acad Sci U S A, 1990 (new tab)
- Glass M et al. Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience, 1997 (new tab)
- Engeli S et al. Activation of the peripheral endocannabinoid system in human obesity. Diabetes, 2005 (new tab)
- Wright K et al. Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing. Gastroenterology, 2005 (new tab)
Cited values
- CB1AgonistKd = 0 nM · not specified in the abstract100 out of 100
Devane et al. 1992, J Med Chem (new tab) · binding of the tritiated ligand to the cannabinoid receptor; precursor Ki 0.18 nM, CP-55,940 2.0 nM in the same study
Pharmacology
HU-243 is a synthetic cannabimimetic agonist of extreme affinity, described in 1992 by Devane, Breuer, Sheskin, Järbe, Eisen and Mechoulam as a « probe » of the cannabinoid receptor. It is the hexahydro analogue of HU-210, which the authors presented as the most potent cannabimimetic substance known at the time; they isolate its equatorial epimer. Its dissociation constant (KD) at the cannabinoid receptor is 45 pM, against a Ki of 180 pM for the unsaturated precursor and 2.0 nM for CP-55,940. In the Δ1-THC discrimination test in pigeons, its ED50 is 0.002 mg/kg at 4.5 h, at the potency level of the precursor. Its tritiated version served as a probe of the receptor. No human data were found.
Key sources.
- Devane WA, Breuer A, Sheskin T, Järbe TU, Eisen MS, Mechoulam R. A novel probe for the cannabinoid receptor. J Med Chem. 1992;35(11):2065-2069 (new tab)PMID 1317925
- Yan G, Yin D, Khanolkar AD, Compton DR, Martin BR, Makriyannis A. Synthesis and pharmacological properties of 11-hydroxy-3-(1',1'-dimethylheptyl)hexahydrocannabinol: a high-affinity cannabinoid agonist. J Med Chem. 1994;37(16):2619-2622 (new tab)PMID 8057304
- Council Framework Decision 2004/757/JHA, consolidated version of 12.01.2026 (annex: substances subject to Union control) (new tab)
History
- Source
- A wholly synthetic compound, absent from cannabis and from every living organism, described in 1992 by Devane, Breuer, Sheskin, Järbe, Eisen and Mechoulam as a probe of the cannabinoid receptor, in tritiated form (Devane et al. 1992). No report of circulation outside the laboratory was found in the sources consulted.
Origin
Laboratory synthesis
No biological pathway: HU-243 is entirely synthetic; it is the hexahydro analogue, with a 1,1-dimethylheptyl chain and a hydroxymethyl group at position 9, of the cannabinoid HU-210.
Legal framework
- European Union
It does not appear in the annex to Framework Decision 2004/757/JHA (consolidated version of 12 January 2026), which names only five synthetic cannabinoid agonists: MDMB-CHMICA, ADB-CHMINACA, CUMYL-4CN-BINACA, MDMB-4en-PINACA and 4F-MDMB-BICA. Nor does it appear in annex III of the consolidated ANSM list (tables I and II of the 1971 Convention on Psychotropic Substances).
- France
A narcotic listed by name in France: the consolidated ANSM list (updated 16 February 2026) cites in annex IV « HU-243 ou (6aR, 9R, 10aR)-9-(hydroxyméthyl)-6,6-diméthyl-3-(2-méthyloctan-2-yl)-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-1-ol », in the list of cannabinoids covered with their isomers, stereoisomers, esters, ethers and salts, where HU-210 and WIN 55,212-2 also appear. The list gives no date specific to the HU-243 entry.
Sources: EUR-Lex, UNODC, CND, ANSM, IUPHAR/BPS, ChEBI, EUDA. Our method.
Classification
Family, origin and source verification
- Family
Synthetic CB receptor agonist › Research ligand or medicine
- Class
classical
- Verification
Classification, sources and binding values checked on 20 October 2026; text read against its sources and Wikipedia.
- Wikipedia (English)
Article paired by the molecule's structure (InChIKey), revision read on 19 October 2026. Read as a second opinion, never cited as a source.
References
- Devane WA, Breuer A, Sheskin T, Järbe TU, Eisen MS, Mechoulam R. A novel probe for the cannabinoid receptor. J Med Chem. 1992;35(11):2065-2069 (new tab)PMID 1317925
- Yan G, Yin D, Khanolkar AD, Compton DR, Martin BR, Makriyannis A. Synthesis and pharmacological properties of 11-hydroxy-3-(1',1'-dimethylheptyl)hexahydrocannabinol: a high-affinity cannabinoid agonist. J Med Chem. 1994;37(16):2619-2622 (new tab)PMID 8057304
- Council Framework Decision 2004/757/JHA, consolidated version of 12.01.2026 (annex: substances subject to Union control) (new tab)
Identifiers
Names
- Common name
- HU-243 (7-hydroxy-hexahydrocannabinol-DMH)
- IUPAC name
- (6aR,9R,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-1-ol
- Other names
- HU-243 · AM-4056 · 7-hydroxy-hexahydrocannabinol-DMH
Identifiers
- Formula
- C₂₅H₄₀O₃
- CAS
- 140835-14-9
- PubChem CID
- 5311171(new tab)
- InChIKey
- MVEVPDCVOXJVBD-MISYRCLQSA-N
- SMILES
- CCCCCCC(C)
(C) C1= CC(= C2[C@@H] 3C[C@@H] (CC[C@H] 3C(OC2= C1) (C) C) CO) O
LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.